{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T12:14:34Z","timestamp":1775909674416,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.amjcard.2010.06.059","type":"journal-article","created":{"date-parts":[[2010,10,27]],"date-time":"2010-10-27T08:20:18Z","timestamp":1288167618000},"page":"1307-1312","source":"Crossref","is-referenced-by-count":28,"title":["Comparison of Acute Reduction in Left Ventricular Outflow Tract Pressure Gradient in Obstructive Hypertrophic Cardiomyopathy by Disopyramide Versus Pilsicainide Versus Cibenzoline"],"prefix":"10.1016","volume":"106","author":[{"given":"Katsuya","family":"Kajimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taku","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Minami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kasanuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2010.06.059_bib1","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJM198210143071607","article-title":"Muscular subaortic stenosis: hemodynamic and clinical improvement after disopyramide","volume":"307","author":"Pollick","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2010.06.059_bib2","first-page":"1085","article-title":"Disopyramide in hypertrophic cardiomyopathy: hemodynamic assessment after intravenous administration","volume":"62","author":"Pollick","year":"1988","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2010.06.059_bib3","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/0002-8703(93)90760-7","article-title":"Acute dose\u2013response effects of intravenous disopyramide in hypertrophic obstructive cardiomyopathy","volume":"125","author":"Kimball","year":"1993","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2010.06.059_bib4","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/01.CIR.38.5.846","article-title":"Muscular subaortic stenosis: prevention of outflow obstruction with propranolol","volume":"38","author":"Flamm","year":"1968","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2010.06.059_bib5","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/hrt.44.5.488","article-title":"Effects of propranolol on myocardial oxygen consumption, substrate extraction, and haemodynamics in hypertrophic obstructive cardiomyopathy","volume":"44","author":"Thompson","year":"1980","journal-title":"Br Heart J"},{"key":"10.1016\/j.amjcard.2010.06.059_bib6","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1161\/01.CIR.60.6.1201","article-title":"Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy","volume":"60","author":"Rosing","year":"1979","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2010.06.059_bib7","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/01.CIR.64.3.437","article-title":"Verapamil; its potential for causing serious complications in patients with hypertrophic cardiomyopathy","volume":"64","author":"Epstein","year":"1981","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2010.06.059_bib8","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/hrt.51.5.523","article-title":"Hypertrophic obstructive cardiomyopathy: effects of acute and chronic verapamil treatment on left ventricular systolic and diastolic function","volume":"51","author":"Anderson","year":"1984","journal-title":"Br Heart J"},{"key":"10.1016\/j.amjcard.2010.06.059_bib9","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1253\/jcj.61.979","article-title":"The rise time of the monophasic action potential: a new index of local use-dependent conductivity by sodium channel blockers in human myocardium","volume":"61","author":"Shinozaki","year":"1997","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.amjcard.2010.06.059_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1253\/jcj.63.1","article-title":"Profiles of aprindine, cibenzoline, pilsicainide and pirmenol in the framework of the Sicilian Gambit","volume":"63","author":"Kodama","year":"1999","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.amjcard.2010.06.059_bib11","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1161\/01.CIR.96.5.1520","article-title":"Class 1a antiarrhythmic drug cibenziline: a new approach to the medical treatment of hypertrophic obstructive cardiomyopathy","volume":"96","author":"Hamada","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2010.06.059_bib12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ijcard.2008.11.088","article-title":"Synergistic effect of dual chamber pacing and disopyramide in obstructive hypertrophic cardiomyopathy","volume":"141","author":"Minami","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjcard.2010.06.059_bib13","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/eurjhf\/hfp166","article-title":"Possible acute and chronic synergic effect of dual chamber pacing and disopyramide in obstructive hypertrophic cardiomyopathy: a case report","volume":"12","author":"Haruki","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.amjcard.2010.06.059_bib14","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1253\/circj.71.1540","article-title":"Effect of intravenous administration of cibenzoline on left ventricular diastolic pressures in patients with hypertrophic cardiomyopathy","volume":"71","author":"Hamada","year":"2007","journal-title":"Circ J"},{"key":"10.1016\/j.amjcard.2010.06.059_bib15","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejphar.2009.02.040","article-title":"Effect of pilsicainide on dominant frequency in the right and left atria and pulmonary veins during atrial fibrillation: association with its atrial fibrillation terminating effect","volume":"608","author":"Horiuchi","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.amjcard.2010.06.059_bib16","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.jacc.2005.01.012","article-title":"Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy","volume":"45","author":"Sherrid","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2010.06.059_bib17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1056\/NEJMoa021332","article-title":"Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy","volume":"348","author":"Maron","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2010.06.059_bib18","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0735-1097(03)00941-0","article-title":"American College of Cardiology\/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy","volume":"42","author":"Maron","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2010.06.059_bib19","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/000331979905000410","article-title":"Effect of disopyramide on left ventricular pressure gradient in hypertrophic obstructive cardiomyopathy in comparison with propranolol\u2014a case report","volume":"50","author":"Tokudome","year":"1999","journal-title":"Angiology"},{"key":"10.1016\/j.amjcard.2010.06.059_bib20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0306-3623(89)90070-0","article-title":"Evidence that the Na+-Ca2+ exchange system is related to the antiarrhythmic action of disopyramide","volume":"20","author":"Sakai","year":"1989","journal-title":"Gen Pharmacol"},{"key":"10.1016\/j.amjcard.2010.06.059_bib21","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1476-5381.1986.tb14588.x","article-title":"Inhibition of the myocardial Ca2+ inward current by the class 1 antiarrhythmic agent, cibenzoline","volume":"87","author":"Holck","year":"1986","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.amjcard.2010.06.059_bib22","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/0002-9149(88)90553-X","article-title":"Oral disopyramide therapy for obstructive hypertrophic cardiomyopathy","volume":"62","author":"Sherrid","year":"1988","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2010.06.059_bib23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1161\/01.CIR.97.1.41","article-title":"Mechanism of benefit of negative inotropes in obstructive hypertrophic cardiomyopathy","volume":"97","author":"Sherrid","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2010.06.059_bib24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.pcad.2006.08.001","article-title":"Pathophysiology and treatment of hypertrophic cardiomyopathy","volume":"49","author":"Sherrid","year":"2006","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.amjcard.2010.06.059_bib25","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000177052","article-title":"Effects of intravenous disopyramide on coronary hemodynamics and vasodilator reserve in hypertrophic obstructive cardiomyopathy","volume":"87","author":"Hongo","year":"1996","journal-title":"Cardiology"},{"key":"10.1016\/j.amjcard.2010.06.059_bib26","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S0735-1097(00)00830-5","article-title":"Systolic anterior motion begins at low left ventricular outflow tract velocity in obstructive hypertrophic cardiomyopathy","volume":"36","author":"Sherrid","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2010.06.059_bib27","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/0735-1097(95)00229-W","article-title":"Salutary effect of disopyramide on left ventricular diastolic function in hypertrophic obstructive cardiomyopathy","volume":"26","author":"Matsubara","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2010.06.059_bib28","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1001\/jama.287.10.1308","article-title":"Hypertrophic cardiomyopathy: A systematic review","volume":"287","author":"Maron","year":"2002","journal-title":"JAMA"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914910013792?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914910013792?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T06:53:00Z","timestamp":1544165580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914910013792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0002914910013792"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2010.06.059","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}